CORTESI, PAOLO ANGELO

CORTESI, PAOLO ANGELO  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 173 (tempo di esecuzione: 0.055 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review 01 - Articolo su rivista 2024 Antonazzo, Ippazio CosimoLa Vecchia, AdrianoFerrara, PietroPiraino, AlexandraCortesi, Paolo AngeloMantovani, Lorenzo Giovanni +
Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database 01 - Articolo su rivista 2024 Antonazzo, Ippazio CosimoCortesi, Paolo AngeloFornari, CarlaGnesi, MarcoMantovani, Lorenzo GiovanniMazzaglia, Giampiero +
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 01 - Articolo su rivista 2024 Carugno, AndreaConti, SaraCortesi, Paolo AngeloFerrara, PietroFornari, CarlaMantovani, Lorenzo Giovanni +
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 01 - Articolo su rivista 2024 Antonazzo, Ippazio CosimoCarugno, AndreaCortesi, Paolo AngeloFerrara, PietroMantovani, Lorenzo Giovanni +
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 01 - Articolo su rivista 2024 Carugno, AndreaCortesi, Paolo AngeloMantovani, Lorenzo Giovanni +
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 01 - Articolo su rivista 2024 Carugno, AndreaCortesi, Paolo AngeloMantovani, Lorenzo Giovanni +
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 01 - Articolo su rivista 2024 Cortesi P. A.Fornari A. +
Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis 01 - Articolo su rivista 2024 Cortesi, Paolo AngeloAntonazzo, Ippazio CosimoMazzaglia, GiampieroMantovani, Lorenzo Giovanni +
Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients 01 - Articolo su rivista 2024 Antonazzo I. C.Cortesi P. A.Mantovani L. G. +
The psychosocial impact of haemophilia from patients’ and caregivers’ point of view: The results of an Italian survey 01 - Articolo su rivista 2024 Fornari A.Antonazzo I. C.Facchetti R.Cortesi P. A.Mantovani L. G. +
The value‐based healthcare approach to haemophilia: Development of outcome measures for the evaluation of care of people with haemophilia 01 - Articolo su rivista 2024 Cortesi, PAFornari, CConti, SFornari, AMantovani, LG +
Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database 01 - Articolo su rivista 2024 Antonazzo ICRozza DConti SFornari CCortesi PAMantovani LGMazzaglia G +
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy 01 - Articolo su rivista 2023 Zambelli A.Cazzaniga M.Antonazzo I. C.Mantovani L. G.Cortesi P. A. +
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy 01 - Articolo su rivista 2023 Cortesi P. A.Fornari C.Antonazzo I. C.Ritrovato D.Mantovani L. G. +
Cost-Effectiveness of the Early Arthritis Clinic Organizational Model 01 - Articolo su rivista 2023 Zanetti, AZambon, AMantovani, LGCortesi, PAScire', CA +
Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation 01 - Articolo su rivista 2023 Cortesi P. A.Conti S.Mantovani L. G.Belli L. S. +
Editorial: treat-to-target in ulcerative colitis clinical management—a small price to pay? Authors' reply 01 - Articolo su rivista 2023 Cortesi P. A.Mantovani L. G. +
Global Burden of Cardiovascular Diseases and Risks, 1990-2022 01 - Articolo su rivista 2023 Conti S.Cortesi P. A.Ferrara P.Fornari C. +
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019 01 - Articolo su rivista 2023 Cortesi P. A.Fornari C.Conti S.Antonazzo I. C.Ferrara P.Mazzaglia G.Mantovani L. G. +
Il carico di malattia associato ai virus dell'epatite B e C in Europa. Dati dal Global Burden of Disease Study 2019 02 - Intervento a convegno 2023 Fornari, CCortesi, PAAntonazzo, ICConti, SMazzaglia, GMantovani, LG